{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:22Z","timestamp":1781636182663,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY026877"],"award-info":[{"award-number":["P30 EY026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To assess the association between inherited retinal diseases (IRDs) and mental health outcomes, specifically examining the prevalence of depression and anxiety compared to general population estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA 2020 guidelines, we conducted a search of PubMed\/MEDLINE, Scopus, Ovid, and Web of Science from inception through April 2025. Studies reporting quantitative prevalence data for depression and\/or anxiety in IRD patients using validated instruments or standardized diagnostic criteria were included. Random-effects meta-analyses using the DerSimonian-Laird method with Freeman-Tukey double arcsine transformation were performed. Heterogeneity was assessed using I\u00b2 statistics, and methodological quality was evaluated using the Newcastle-Ottawa Scale. Subgroup analyses examined prevalence by disease type, and sensitivity analyses tested result robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixteen studies encompassing 12,868 participants met inclusion criteria. The pooled depression prevalence was 31.0% (95% CI: 22.1%-40.6%; I\u00b2 = 93.9%), substantially exceeding general population rates. Anxiety prevalence was 29.3% (95% CI: 17.1%-43.3%; I\u00b2 = 94.3%). Subgroup analysis revealed depression prevalence of 30.6% (95% CI: 22.4%-39.4%) for Retinitis Pigmentosa and 42.5% (95% CI: 0.0%-97.7%) for Stargardt disease. Other IRDs were represented by a single study reporting 14.6% prevalence. The test for subgroup differences approached statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.08). Sensitivity analyses confirmed result robustness despite substantial heterogeneity. Publication bias assessment suggested potential overestimation of depression prevalence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with IRDs experience a substantial mental health burden, with depression and anxiety prevalence markedly exceeding general population rates. These findings underscore the critical need for mental health screening integrated into routine ophthalmologic care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00820-7","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:39:49Z","timestamp":1771573189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mental health outcomes in patients with inherited retinal diseases: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Hashem","family":"Abu Serhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oase","family":"Sbei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Kojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrukh","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashra","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Sheraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al-Moujahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"9549","key":"820_CR1","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795\u2013809. https:\/\/doi.org\/10.1016\/S0140-6736(06)69740-7.","journal-title":"Lancet"},{"issue":"4","key":"820_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ophtha.2015.12.009","volume":"123","author":"RW Strauss","year":"2016","unstructured":"Strauss RW, Ho A, Mu\u00f1oz B, et al. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies. Ophthalmology. 2016;123(4):817\u201328. https:\/\/doi.org\/10.1016\/j.ophtha.2015.12.009.","journal-title":"Ophthalmology"},{"issue":"3","key":"820_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1017\/S1041610205002905","volume":"18","author":"K Berman","year":"2006","unstructured":"Berman K, Brodaty H. Psychosocial effects of age-related macular degeneration. Int Psychogeriatr. 2006;18(3):415\u201328. https:\/\/doi.org\/10.1017\/S1041610205002905.","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"820_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s11136-011-0061-y","volume":"21","author":"GIJM Kempen","year":"2012","unstructured":"Kempen GIJM, Ballemans J, Ranchor AV, Van Rens GHMB, Zijlstra GAR. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services. Qual Life Res. 2012;21(8):1405\u201311. https:\/\/doi.org\/10.1007\/s11136-011-0061-y.","journal-title":"Qual Life Res"},{"issue":"2","key":"820_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1167\/iovs.14-15848","volume":"56","author":"HPA Van Der Aa","year":"2015","unstructured":"Van Der Aa HPA, Comijs HC, Penninx BWJH, Van Rens GHMB, Van Nispen RMA. Major Depressive and Anxiety Disorders in Visually Impaired Older Adults. Investig Ophthalmol Vis Sci. 2015;56(2):849\u201354. https:\/\/doi.org\/10.1167\/iovs.14-15848.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"820_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/bjo.2007.127092","volume":"92","author":"BJ Hahm","year":"2008","unstructured":"Hahm BJ, Shin YW, Shim EJ, et al. Depression and the vision-related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol. 2008;92(5):650\u20134. https:\/\/doi.org\/10.1136\/bjo.2007.127092.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"820_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/2474126420936455","volume":"5","author":"P Le","year":"2021","unstructured":"Le P, Nguyen M, Vu T, Dao DP, Olson D, Zhang AY. Anxiety and Depression in Patients With Retinitis Pigmentosa. J VitreoRetin Dis. 2021;5(2):114\u201320. https:\/\/doi.org\/10.1177\/2474126420936455.","journal-title":"J VitreoRetin Dis"},{"issue":"2","key":"820_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/13816810.2020.1855663","volume":"42","author":"A Roborel de Climens","year":"2021","unstructured":"Roborel de Climens A, Tugaut B, Dias Barbosa C, Buggage R, Brun-Strang C. Living with Stargardt disease: insights from patients and their parents. Ophthalmic Genet. 2021;42(2):150\u201360. https:\/\/doi.org\/10.1080\/13816810.2020.1855663.","journal-title":"Ophthalmic Genet"},{"issue":"30 1","key":"820_CR9","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1136\/bmj.e542","volume":"344","author":"ME Cupples","year":"2012","unstructured":"Cupples ME, Hart PM, Johnston A, Jackson AJ. Improving healthcare access for people with visual impairment and blindness. BMJ. 2012;344(30 1):e542\u2013542. https:\/\/doi.org\/10.1136\/bmj.e542.","journal-title":"BMJ"},{"key":"820_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"820_CR11","unstructured":"Ottawa Hospital Research Institute. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed May 3. 2024."},{"issue":"1","key":"820_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1590\/0047-2085000000257","volume":"69","author":"MLS Gomes","year":"2020","unstructured":"Gomes MLS, Corr\u00eaa H, Duarte D, R\u00fcckl S, Brancaglion MYM, Frasson M. Depression and quality of life in individuals with stargardt\u2019s disease. J Bras Psiquiatr. 2020;69(1):44\u20137. https:\/\/doi.org\/10.1590\/0047-2085000000257.","journal-title":"J Bras Psiquiatr"},{"issue":"5","key":"820_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/OPX.0b013e31828dee0a","volume":"90","author":"S Kim","year":"2013","unstructured":"Kim S, Shin DW, An AR, et al. Mental health of people with retinitis Pigmentosa. Optom Vis Sci. 2013;90(5):488\u201393. https:\/\/doi.org\/10.1097\/OPX.0b013e31828dee0a.","journal-title":"Optom Vis Sci"},{"issue":"4","key":"820_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/08820538.2015.1118136","volume":"32","author":"G Yioti","year":"2017","unstructured":"Yioti G, Stefaniotou M, Ziavrou I, Kotsis K, Hyphantis T, Illness Perceptions. Psychiatric Manifestations, and Quality of Life in Patients with Inherited Retinal Dystrophies. Semin Ophthalmol. 2017;32(4):428\u201337. https:\/\/doi.org\/10.3109\/08820538.2015.1118136.","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"820_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000435886","volume":"54","author":"L Azoulay","year":"2015","unstructured":"Azoulay L, Chaumet-Riffaud P, Jaron S, et al. Threshold Levels of Visual Field and Acuity Loss Related to Significant Decreases in the Quality of Life and Emotional States of Patients with Retinitis Pigmentosa. Ophthalmic Res. 2015;54(2):78\u201384. https:\/\/doi.org\/10.1159\/000435886.","journal-title":"Ophthalmic Res"},{"issue":"11","key":"820_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jamaophthalmol.2024.3641","volume":"142","author":"HR Kim","year":"2024","unstructured":"Kim HR, Lee NK, Suh Y, et al. Incidence and Risk of Depressive Disorder in Patients with Retinitis Pigmentosa. JAMA Ophthalmol. 2024;142(11):997\u20131004. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.3641.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"820_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.11144\/javeriana.upsy10-2.dapr","volume":"10","author":"MD L\u00f3pez-Justicia","year":"2011","unstructured":"L\u00f3pez-Justicia MD, S\u00e1nchez TP, Jim\u00e9nez CF, L\u00f3pez HC, Batanero CD, Medina AC. Depression and anxiety in people with retinitis pigmentosa, their family and a control group. Univ Psychol. 2011;10(2):467\u201376. https:\/\/doi.org\/10.11144\/javeriana.upsy10-2.dapr.","journal-title":"Univ Psychol"},{"issue":"3","key":"820_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5301\/ejo.5000700","volume":"26","author":"MM Moschos","year":"2015","unstructured":"Moschos MM, Nitoda E, Lavaris A. Estimation of depression prevalence in patients with stargardt disease using PHQ-9 and zung scores. Eur J Ophthalmol. 2015;26(3):268\u201372. https:\/\/doi.org\/10.5301\/ejo.5000700.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"820_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4274\/tjo.galenos.2024.77489","volume":"54","author":"A \u00d6ner","year":"2024","unstructured":"\u00d6ner A, Sinim Kahraman N, Sevik MO, Kelek T\u00fcl\u00fc K, \u015eahin \u00d6, \u00d6zsoy S. Emotional State Evaluation of Retinitis Pigmentosa Patients with the Beck Depression Inventory. Turk Jour Ophthalmol. 2024;54(4):205\u201311. https:\/\/doi.org\/10.4274\/tjo.galenos.2024.77489.","journal-title":"Turk Jour Ophthalmol"},{"issue":"4","key":"820_CR20","first-page":"523","volume":"43","author":"F Adhami-Moghadam","year":"2014","unstructured":"Adhami-Moghadam F, Iran-Pour E. Psychological disorders in patients with retinitis pigmentosa in iran. Iran J Public Health. 2014;43(4):523\u20138.","journal-title":"Iran J Public Health"},{"issue":"12","key":"820_CR21","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/OPX.0b013e3182348d0b","volume":"88","author":"AK Bittner","year":"2011","unstructured":"Bittner AK, Ibrahim MA, Haythornthwaite JA, Diener-West M, Dagnelie G. Vision test variability in retinitis pigmentosa and psychosocial factors. Optom Vis Sci. 2011;88(12):1496\u2013506. https:\/\/doi.org\/10.1097\/OPX.0b013e3182348d0b.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"820_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.6018\/analesps.32.3.218081","volume":"32","author":"H Chac\u00f3n-L\u00f3pez","year":"2016","unstructured":"Chac\u00f3n-L\u00f3pez H, L\u00f3pez-Justicia MD. Relationship between self-concept and depression level in people with retinitis Pigmentosa. Psicol. 2016;32(3):820\u20137. https:\/\/doi.org\/10.6018\/analesps.32.3.218081.","journal-title":"Psicol"},{"key":"820_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ajo.2017.02.016","volume":"177","author":"AE Chaumet-Riffaud","year":"2017","unstructured":"Chaumet-Riffaud AE, Chaumet-Riffaud P, Cariou A, et al. Impact of Retinitis Pigmentosa on Quality of Life, Mental Health, and Employment Among Young Adults. Am J Ophthalmol. 2017;177:169\u201374. https:\/\/doi.org\/10.1016\/j.ajo.2017.02.016.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"820_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000539116","volume":"67","author":"A Humphries","year":"2024","unstructured":"Humphries A, Bowman L, Nguyen T, et al. Quality of Life Analysis in Patients with Retinitis Pigmentosa. Ophthalmic Res. 2024;67(1):348\u201357. https:\/\/doi.org\/10.1159\/000539116.","journal-title":"Ophthalmic Res"},{"issue":"4","key":"820_CR25","doi-asserted-by":"publisher","first-page":"e0195983","DOI":"10.1371\/journal.pone.0195983","volume":"13","author":"M Sainohira","year":"2018","unstructured":"Sainohira M, Yamashita T, Terasaki H, et al. Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa. PLoS ONE. 2018;13(4):e0195983. https:\/\/doi.org\/10.1371\/journal.pone.0195983.","journal-title":"PLoS ONE"},{"issue":"3","key":"820_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1399-0004.1996.tb02366.x","volume":"50","author":"ML Tamayo","year":"1996","unstructured":"Tamayo ML, Maldonado C, Plaza SL, et al. Neuroradiology and clinical aspects of Usher syndrome. Clin Genet. 1996;50(3):126\u201332. https:\/\/doi.org\/10.1111\/j.1399-0004.1996.tb02366.x.","journal-title":"Clin Genet"},{"issue":"1","key":"820_CR27","doi-asserted-by":"publisher","first-page":"15189","DOI":"10.1038\/s41598-024-66170-2","volume":"14","author":"N Gouveia","year":"2024","unstructured":"Gouveia N, Chukwunalu O, Oliveira C, et al. Exploring self-reported visual function and vision-related anxiety in patients with RPGR-associated retinal degeneration. Sci Rep. 2024;14(1):15189. https:\/\/doi.org\/10.1038\/s41598-024-66170-2.","journal-title":"Sci Rep"},{"issue":"3","key":"820_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00004356-198009000-00005","volume":"3","author":"PC Stogner","year":"1980","unstructured":"Stogner PC. The effects of typical retinitis pigmentosa, Leber\u02bcs congenital amaurosis, centro-peripheral dystrophy, and Usher\u02bcs syndrome on educational and vocational success and personality development. Int J Rehabil Res. 1980;3(3):357\u201366. https:\/\/doi.org\/10.1097\/00004356-198009000-00005.","journal-title":"Int J Rehabil Res"},{"key":"820_CR29","unstructured":"Depressive disorder (depression). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression. Accessed October 28. 2025."},{"issue":"1","key":"820_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s43045-023-00315-3","volume":"30","author":"SF Javaid","year":"2023","unstructured":"Javaid SF, Hashim IJ, Hashim MJ, Stip E, Samad MA, Ahbabi AA. Epidemiology of anxiety disorders: global burden and sociodemographic associations. Middle East Curr Psychiatry. 2023;30(1):44. https:\/\/doi.org\/10.1186\/s43045-023-00315-3.","journal-title":"Middle East Curr Psychiatry"},{"key":"820_CR31","doi-asserted-by":"publisher","first-page":"251584142210901","DOI":"10.1177\/25158414221090100","volume":"14","author":"ZS Ulhaq","year":"2022","unstructured":"Ulhaq ZS, Soraya GV, Dewi NA, Wulandari LR. The prevalence of anxiety symptoms and disorders among ophthalmic disease patients. Ther Adv Ophthalmol. 2022;14:25158414221090100. https:\/\/doi.org\/10.1177\/25158414221090100.","journal-title":"Ther Adv Ophthalmol"},{"issue":"1","key":"820_CR32","doi-asserted-by":"publisher","first-page":"46453","DOI":"10.1038\/srep46453","volume":"7","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Wu X, Lin X, Lin H. The Prevalence of Depression and Depressive Symptoms among Eye Disease Patients: A Systematic Review and Meta-analysis. Sci Rep. 2017;7(1):46453. https:\/\/doi.org\/10.1038\/srep46453.","journal-title":"Sci Rep"},{"key":"820_CR33","doi-asserted-by":"publisher","unstructured":"Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009;190(S7). https:\/\/doi.org\/10.5694\/j.1326-5377.2009.tb02471.x.","DOI":"10.5694\/j.1326-5377.2009.tb02471.x"},{"issue":"11","key":"820_CR34","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3390\/jcm13113081","volume":"13","author":"WSW Tang","year":"2024","unstructured":"Tang WSW, Lau NXM, Krishnan MN, Chin YC, Ho CSH. Depression and Eye Disease\u2014A Narrative Review of Common Underlying Pathophysiological Mechanisms and their Potential Applications. JCM. 2024;13(11):3081. https:\/\/doi.org\/10.3390\/jcm13113081.","journal-title":"JCM"},{"key":"820_CR35","doi-asserted-by":"publisher","unstructured":"Cimarolli V, Casten R, Rovner B, Heyl V, S\u00f6rensen S, Horowitz A. Anxiety and depression in patients with advanced macular degeneration: current perspectives. Ophthalmol Ther. 2015;55. https:\/\/doi.org\/10.2147\/OPTH.S80489.","DOI":"10.2147\/OPTH.S80489"},{"key":"820_CR36","doi-asserted-by":"publisher","unstructured":"Arikian SR, Gorman JM. A review of the diagnosis, pharmacologic treatment, and economic aspects of anxiety disorders. Prim Care Companion CNS Disord. 2001;3(3). https:\/\/doi.org\/10.4088\/PCC.v03n0302.","DOI":"10.4088\/PCC.v03n0302"},{"issue":"3","key":"820_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1176\/ajp.152.3.352","volume":"152","author":"Health care costs","year":"1995","unstructured":"Health care costs. associated with depressive and anxiety disorders in primary care. AJP. 1995;152(3):352\u20137. https:\/\/doi.org\/10.1176\/ajp.152.3.352.","journal-title":"AJP"},{"issue":"4","key":"820_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1365-2869.2001.00271.x","volume":"10","author":"D Ionescu","year":"2001","unstructured":"Ionescu D, Driver HS, Heon E, Flanagan J, Shapiro CM. Sleep and daytime sleepiness in retinitis pigmentosa patients. J Sleep Res. 2001;10(4):329\u201335. https:\/\/doi.org\/10.1046\/j.1365-2869.2001.00271.x.","journal-title":"J Sleep Res"},{"issue":"5","key":"820_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/bjo.2003.036046","volume":"89","author":"RZ Hayeems","year":"2005","unstructured":"Hayeems RZ. How patients experience progressive loss of visual function: a model of adjustment using qualitative methods. Br J Ophthalmol. 2005;89(5):615\u201320. https:\/\/doi.org\/10.1136\/bjo.2003.036046.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"820_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13816810701201930","volume":"28","author":"D Jangra","year":"2007","unstructured":"Jangra D, Ganesh A, Thackray R, et al. Psychosocial adjustment to visual loss in patients with retinitis pigmentosa. Ophthalmic Genet. 2007;28(1):25\u201330. https:\/\/doi.org\/10.1080\/13816810701201930.","journal-title":"Ophthalmic Genet"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00820-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:33:05Z","timestamp":1781634785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00820-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00820-7","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}